US2018258137A1PendingUtilityA1
Control of copolymer compositions
Assignee: MOMENTA PHARMACEUTICALS INCPriority: Apr 3, 2009Filed: May 15, 2018Published: Sep 13, 2018
Est. expiryApr 3, 2029(~2.7 yrs left)· nominal 20-yr term from priority
C07K 14/001C07K 5/10A61P 37/00
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods of making copolymers are described.
Claims
exact text as granted — not AI-modified1 . (canceled)
2 . A method for preparing a composition comprising purified glatiramer acetate having a pyroglutamate concentration of 2000-7000 ppm and a Mp of 5000-9000 Da, comprising:
polymerizing N-carboxy anhydrides of L-alanine, benzyl-protected L-glutamic acid, trifluoroacetic acid (TFA) protected L-lysine and L-tyrosine to generate a protected copolymer (Intermediate-1); treating the Intermediate-1 with HBr and acetic acid to partially depolymerize the protected copolymer and deprotect benzyl-protected L-glutamic acid thereby generating a partially depolymerized product; treating the partially depolymerized product with piperidine to deprotect TFA-protected lysines thereby generating glatiramer acetate; and purifying the glatiramer acetate to create purified glatiramer acetate having a pyro-Glu concentration of 2000-7000 ppm and a Mp of 5000-9000 Da, wherein the amount of water present during the entirety of the depolymerization reaction is controlled to be within 5-25% weight/weight against intermediate-1 present at the beginning of the depolymerization reaction.
3 . The method of claim 2 wherein the Intermediate-1 treated with HBr and acetic acid is not dry.
4 . The method of claim 2 further comprising adding water at the start of the depolymerization reaction or during the depolymerization reaction.
5 . The method of claim 2 , wherein the amount of water present during the entirety of the depolymerization reaction is controlled to be within 8-14% w/w against Intermediate-1 present at the beginning of the depolymerization reaction.
6 . The method of claim 2 , wherein the amount of water present during the entirety of the depolymerization reaction is controlled to be within 10-20% w/w against Intermediate-1 present at the beginning of the depolymerization reaction.
7 . The method of claim 2 , wherein the amount of water present during the entirety of the depolymerization reaction is controlled to be within 7-15% w/w against Intermediate-1 present at the beginning of the depolymerization reaction.
8 . The method of claim 2 , wherein the amount of water present during the entirety of the depolymerization reaction is controlled to be within 9-13% w/w against Intermediate-1 present at the beginning of the depolymerization reaction.
9 . The method of claim 2 wherein the amount of water present during the entirety of the depolymerization reaction is controlled to be within 10-12% w/w against Intermediate-1 present at the beginning of the depolymerization reaction.
10 . The method of claim 2 , wherein the depolymerization proceeds for at least 25 hrs.
11 . The method of claim 2 , wherein the depolymerization proceeds for at least 30 hrs.
12 . The method of claim 2 , wherein the depolymerization proceeds for at least 40 hrs.
13 . The method of claim 2 , wherein the depolymerization reaction comprises contacting the protected copolymer with a solution comprising phenol, HBr and acetic acid.
14 . The method of claim 2 , wherein the concentration of pyro-Glu in the purified glatiramer acetate is 2500-5500 ppm.
15 . The method of claim 2 , wherein the concentration of pyro-Glu in the purified glatiramer acetate is 3000-5000 ppm.
16 . The method of claim 2 , wherein the concentration of pyro-Glu in the purified glatiramer acetate is 3500-4500 ppm.
17 . The method of claim 2 , wherein the Mp of the purified glatiramer acetate is 6,500-7,500 Da.
18 . The method of claim 2 , wherein the protected copolymer is isolated and at least partially dried prior to treating the protected copolymer to partially depolymerize the protected copolymer and deprotect benzyl protected groups.
19 . The method of claim 2 , further comprising measuring the amount of water in the depolymerization reaction at least once.
20 . The method of claim 2 , further comprising:
preparing a pharmaceutical composition comprising at least a portion of the purified glatiramer acetate.
21 . A method for preparing a drug product comprising glatiramer acetate having a pyroglutamate concentration of 2000-7000 ppm and a Mp of 5000-9000 Da, comprising:
polymerizing N-carboxy anhydrides of L-alanine, benzyl-protected L-glutamic acid, trifluoroacetic acid (TFA) protected L-lysine and L-tyrosine to generate a protected copolymer (Intermediate-1); treating the Intermediate-1 with HBr and acetic acid to partially depolymerize the protected copolymer and deprotect benzyl-protected L-glutamic acid thereby generating a partially depolymerized product; treating the partially depolymerized product with piperidine to deprotect TFA-protected lysines thereby generating glatiramer acetate; purifying the glatiramer acetate to create purified glatiramer acetate having a pyro-Glu concentration of 2000-7000 ppm and a Mp of 5000-9000 Da; preparing a pharmaceutical composition comprising at least a portion of the purified glatiramer acetate; processing at least a portion of the pharmaceutical composition as a drug product, thereby preparing a drug product, wherein the amount of water present during the entirety of the depolymerization reaction is controlled to be within 5-25% weight/weight against intermediate-1 present at the beginning of the depolymerization reaction.
22 . The method of claim 21 wherein the Intermediate-1 treated with HBr and acetic acid is not dry.
23 . The method of claim 21 further comprising adding water at the start of the depolymerization reaction or during the depolymerization reaction.
24 . The method of claim 21 , wherein the amount of water present during the entirety of the depolymerization reaction is controlled to be within 8-14% w/w against Intermediate-1 present at the beginning of the depolymerization reaction.
25 . The method of claim 21 , wherein the amount of water present during the entirety of the depolymerization reaction is controlled to be within 10-20% w/w against Intermediate-1 present at the beginning of the depolymerization reaction.
26 . The method of claim 21 , wherein the amount of water present during the entirety of the depolymerization reaction is controlled to be within 7-15% w/w against Intermediate-1 present at the beginning of the depolymerization reaction.
27 . The method of claim 21 , wherein the amount of water present during the entirety of the depolymerization reaction is controlled to be within 9-13% w/w against Intermediate-1 present at the beginning of the depolymerization reaction.
28 . The method of claim 21 , wherein the amount of water present during the entirety of the depolymerization reaction is controlled to be within 10-12% w/w against Intermediate-1 present at the beginning of the depolymerization reaction.
29 . The method of claim 21 , wherein the depolymerization proceeds for at least 25 hrs.
30 . The method of claim 21 , wherein the depolymerization proceeds for at least 30 hrs.
31 . The method of claim 21 , wherein the depolymerization proceeds for at least 40 hrs.
32 . The method of claim 21 , wherein the depolymerization reaction comprises contacting the protected copolymer with a solution comprising phenol, HBr and acetic acid.
33 . The method of claim 21 , wherein the concentration of pyro-Glu in the purified glatiramer acetate is 2500-5500 ppm.
34 . The method of claim 21 , wherein the concentration of pyro-Glu in the purified glatiramer acetate is 3000-5000 ppm.
35 . The method of claim 21 , wherein the concentration of pyro-Glu in the purified glatiramer acetate is 3500-4500 ppm.
36 . The method of claim 21 , wherein the Mp of the purified glatiramer acetate is 6,500-7,500 Da.
37 . The method of claim 21 , wherein the protected copolymer is isolated and at least partially dried prior to treating the protected copolymer to partially depolymerize the protected copolymer and deprotect benzyl protected groups.
38 . The method of claim 21 , further comprising measuring the amount of water in the depolymerization reaction at least once.
39 . The method of claim 21 , further comprising:
preparing a pharmaceutical composition comprising at least a portion of the purified glatiramer acetate.Join the waitlist — get patent alerts
Track US2018258137A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.